DV
Dividend Vision

AGIO — Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc. (AGIO)

Total return is 7.3% over the past 13.1 years, 467.2 points behind SPY at 474.5%. Its deepest 1-year drawdown was 50.9%.

AGIO is a single-stock equity position in a healthcare company, not a diversified ETF fund. As an individual pharmaceutical stock rather than a fund with multiple holdings, it does not have traditional ETF characteristics such as a stated distribution frequency, yield rate, or published expense ratio. This security appeals to investors seeking direct exposure to a specific healthcare company rather than those pursuing diversified dividend income strategies.

AGIO key facts

Asset type
Stock
Asset class
Equity
Inception date
07/24/2013
Distribution frequency
None
Last close
$33.56
Market cap
$2,003,595,136
Average volume
1124478.0
Beta
0.586
Payout ratio
0.0
Forward P/E
2.4655
EPS
$-7.01